Commercial driver’s license (CDL) holders with diabetes — including insulin-treated drivers — can operate interstate commercial motor vehicles under FMCSA 49 CFR 391.46, with the Insulin-Treated Diabetes Mellitus Assessment Form (MCSA-5870) completed by their treating clinician. Drivers must be free of severe hypoglycemia for at least 12 months, recertify annually, and most should use a continuous glucose monitor for safety and documentation. Non-insulin diabetes carries fewer restrictions but still requires Medical Examiner certification. Severe hypoglycemia at work is reportable and disqualifying until stability is reestablished.
FMCSA Medical Certification — The Basics
- All interstate CDL holders must pass an FMCSA Medical Examiner exam every 1 to 2 years (annual for diabetes)
- Medical Examiners must be listed on the National Registry of Certified Medical Examiners
- The result is a Medical Examiner’s Certificate (MEC, Form MCSA-5876) and the corresponding entry on the driver’s record
- State CDL agencies receive the certificate electronically
- Intrastate drivers may follow state-specific rules (some states are stricter, some are lighter)
The 2018 Rule Change for Insulin-Treated Diabetes
Until November 2018, insulin-treated commercial drivers needed a Diabetes Exemption from FMCSA — a process involving extensive documentation and a multi-month wait. Under the new Diabetes Exemption Standard (49 CFR 391.46), the exemption letter is no longer required. Instead:
- The treating clinician completes the MCSA-5870 assessment form
- A Certified Medical Examiner reviews the form and issues the MEC
- Recertification occurs at least every 12 months
- The driver self-monitors glucose during driving and reports severe lows
MCSA-5870 Assessment Form — What It Captures
| Section | Detail |
|---|---|
| Diabetes type and date of diagnosis | Type 1, type 2, or other |
| Insulin regimen | Basal-bolus, premixed, pump, or other |
| Recent A1C | Trended over prior 6 to 12 months |
| Hypoglycemia history | Severe events in the prior 12 months; hypoglycemia unawareness |
| Eye exam | Within the prior 12 months — no unstable retinopathy |
| Kidney function | eGFR and microalbumin or ACR |
| Glucose monitoring | CGM use, SMBG frequency |
| Clinician judgment | Statement that the driver is medically qualified |
Why CGM Is Increasingly the Standard
- Real-time low-glucose alerts give drivers an early warning before impairment
- Time-below-range data on the CGM is an objective record for the MCSA-5870
- Trend arrows help drivers decide whether to eat carbs or stop
- Some self-insured fleets reduce insurance premiums for drivers who use CGM
- CGM also benefits non-insulin drivers on sulfonylureas or basal insulin
For deeper context on monitoring metrics, see our guides on time in range and ambulatory glucose profile.
Hypoglycemia at Work — Rules and Reporting
| Event Type | Definition | Action |
|---|---|---|
| Mild hypoglycemia | Symptoms with glucose typically 54-70 mg/dL; driver self-treats | Pull over safely; treat with fast carbs (15 g); recheck in 15 minutes |
| Severe hypoglycemia | Required assistance from another person, or seizure or unconsciousness | Stop driving immediately; report to clinician and employer; disqualifying until stable control demonstrated |
| Hypoglycemia unawareness | No warning symptoms before low glucose | Disqualifying until restored awareness or risk mitigation |
Roadside Emergency Kit for CDL Drivers With Diabetes
- Glucose tablets or gels (15 g portions)
- Glucagon kit (intramuscular or nasal — Baqsimi, Gvoke, or generic)
- Snacks (granola bars, crackers) for delayed meals
- Backup glucose meter and strips
- Spare CGM sensor and receiver/phone charger
- Insulin pen and needles in temperature-stable storage
- Medical ID bracelet or wallet card listing diabetes and emergency contact
- Water and a thermos
Non-Insulin Diabetes — Lighter Requirements
- Metformin, GLP-1 agonists (semaglutide, tirzepatide), DPP-4 inhibitors, SGLT2 inhibitors — generally compatible with CDL driving
- Sulfonylureas (glyburide, glipizide) carry hypoglycemia risk and warrant CGM consideration
- No MCSA-5870 form required (that form is specific to insulin)
- Annual medical exam with the standard MEC form (5876) suffices
- Significant complications (retinopathy, kidney disease, neuropathy affecting feet/vision) require additional review
Lifestyle on the Road
- Truck stop food choices — plan ahead; pack vegetables and protein
- Sleep schedule and shift work affect glucose patterns
- Hydration and frequent short walks at stops
- Foot care — diabetic neuropathy is a real occupational risk for drivers who sit long hours
- Annual eye exam; report any visual changes immediately
- Annual dental check (gum disease worsens glucose control)
Working With Your Employer and Medical Examiner
- Identify a primary diabetes provider who is familiar with the MCSA-5870 form
- Keep recent labs (A1C, kidney function, eye exam) available at every exam
- Bring CGM data downloads or printed AGP reports
- Schedule the FMCSA exam ahead of your CDL renewal
- Inform your employer of insulin or sulfonylurea use per company policy
- HIPAA protects health information — employers receive only certification status, not diagnoses
Related Reading
For another occupational diabetes guide in this batch, see military and diabetes. For glucose-monitoring fundamentals helpful in commercial driving, see time in range and A1C levels.
The Bottom Line
Commercial drivers with diabetes — including those on insulin — can hold a CDL and drive interstate, but the path requires planning. Insulin-treated drivers complete the MCSA-5870 form annually with their treating clinician and a Certified Medical Examiner. Non-insulin diabetes carries fewer restrictions. Continuous glucose monitoring, a glycemic stability record, an emergency kit, and an open relationship with the medical examiner are the practical foundations of safe driving and successful recertification. Severe hypoglycemia is the single most common reason for disqualification — recognizing early symptoms and pulling over safely protects both the driver and the public.
